Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: Results from a case-control study and a meta-analysis

Journal of Neurology

Volumn 259, Issue 1, 2012, Pages 111-118

  Martinez Ramirez, Sergi ^a   Delgado Mederos, Raquel ^a   Marín, Rebeca ^a   Suárez Calvet, Marc ^a   Sáinz, María Pilar ^a   Alejaldre, Aída ^a   Vidal Jordana, Ángela ^a   Martí Vilalta, Josep Lluís ^a   Martí Fàbregas, Joan ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Intracerebral haemorrhage; Meta analysis; Outcome; Statins; t PA; Thrombolysis

Indexed keywords

ALTEPLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE CONTROL STUDY; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PREMEDICATION; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW;

AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INJECTIONS, INTRAVENOUS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84856695321     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6137-3     Document Type: Article

References (26)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581-1587
2. W Hacke, et al. 2008 Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 13 1317 1329 18815396 10.1056/NEJMoa0804656 1:CAS:528:DC%2BD1cXhtFGqu77E
3. J Marti-Fabregas, et al. 2007 Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials Cerebrovasc Dis 23 2-3 85 90 17114877 1:CAS:528:DC%2BD2sXhsFCqt7o%3D (Pubitemid 46239146)
4. N Wahlgren, et al. 2007 Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study Lancet 369 9558 275 282 17258667 10.1016/S0140-6736(07)60149-4 1:CAS:528:DC%2BD2sXpvV2gtw%3D%3D (Pubitemid 46138121)
5. DD Waters, et al. 2006 Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study J Am Coll Cardiol 48 9 1793 1799 17084252 10.1016/j.jacc.2006.07.041 1:CAS:528:DC%2BD28XhtFOjtb%2FJ (Pubitemid 44648630)
6. P Amarenco, et al. 2006 High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 6 549 559 16899775 10.1056/NEJMoa061894 1:CAS:528:DC%2BD28XotVKgtb8%3D (Pubitemid 44202151)
7. L Sironi, et al. 2003 Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage Arterioscler Thromb Vasc Biol 23 2 322 327 12588778 10.1161/01.ATV.0000044458.23905.3B 1:CAS:528:DC%2BD3sXptFyksQ%3D%3D (Pubitemid 36231947)
8. J Chen, et al. 2003 Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke Ann Neurol 53 6 743 751 12783420 10.1002/ana.10555 1:CAS:528:DC%2BD3sXkslGhs7k%3D (Pubitemid 36622511)
9. J Marti-Fabregas, et al. 2004 Favorable outcome of ischemic stroke in patients pretreated with statins Stroke 35 5 1117 1121 15073403 10.1161/01.STR.0000125863.93921.3f 1:CAS:528:DC%2BD2cXjslOrt7w%3D (Pubitemid 38543528)
10. MJ Reeves, et al. 2008 Effect of pretreatment with statins on ischemic stroke outcomes Stroke 39 6 1779 1785 18369173 10.1161/STROKEAHA.107.501700 1:CAS:528:DC%2BD1cXlvFaisbY%3D
11. P Martinez-Sanchez, et al. 2009 The beneficial effect of statins treatment by stroke subtype Eur J Neurol 16 1 127 133 19049507 10.1111/j.1468-1331.2008.02370.x 1:STN:280:DC%2BD1M%2FitlSksw%3D%3D
12. M Giroud, et al. 1995 Risk factors for primary cerebral hemorrhage: a population-based study-the Stroke Registry of Dijon Neuroepidemiology 14 1 20 26 7898603 10.1159/000109775 1:STN:280:DyaK2M3gs1Citw%3D%3D
13. J Alvarez-Sabin, et al. 2007 Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator Stroke 38 3 1076 1078 17272777 10.1161/01.STR.0000258075.58283.8f 1:CAS:528:DC%2BD2sXhslygu74%3D (Pubitemid 46568478)
14. M Uyttenboogaart, et al. 2008 Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke J Neurol 255 6 875 880 18338194 10.1007/s00415-008-0797-7 1:CAS:528:DC%2BD1cXpt1CqsLs%3D
15. Miedema I et al (2010) Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Cerebrovasc Dis 29(3):263-267
16. N Meier, et al. 2009 Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke Stroke 40 5 1729 1737 19265056 10.1161/STROKEAHA.108.532473 1:CAS:528:DC%2BD1MXkvVWmsbc%3D
17. W Hacke, et al. 1998 Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators Lancet 352 9136 1245 1251 9788453 10.1016/S0140-6736(98)08020-9 1:CAS:528: DyaK1cXnt1egtLo%3D (Pubitemid 28470336)
18. W Hacke, et al. 1995 Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA 274 13 1017 1025 7563451 10.1001/jama.1995. 03530130023023 1:CAS:528:DyaK2MXptFWhur0%3D
19. DF Stroup, et al. 2000 Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group J Am Med Assoc 283 15 2008 2012 10.1001/jama.283.15.2008 1:STN:280:DC%2BD3c3kvVGgsA%3D%3D (Pubitemid 30214957)
20. Z Zheng B Chen 2007 Effects of Pravastatin on neuroprotection and neurogenesis after cerebral ischemia in rats Neurosci Bull 23 4 189 197 17687392 1:CAS:528:DC%2BD1cXpsF2gsLg%3D (Pubitemid 47477549)
21. M Blanco, et al. 2007 Statin treatment withdrawal in ischemic stroke: a controlled randomized study Neurology 69 9 904 910 17724294 10.1212/01.wnl. 0000269789.09277.47 1:CAS:528:DC%2BD2sXptl2jsrY%3D (Pubitemid 47329591)
22. RP Byington, et al. 2001 Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project Circulation 103 3 387 392 11157690 1:CAS:528:DC%2BD3MXhtF2ksLc%3D (Pubitemid 32105978)
23. LB Goldstein, et al. 2008 Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study Neurology 70 24 Pt 2 2364 2370 18077795 10.1212/01.wnl.0000296277.63350.77 1:CAS:528:DC%2BD1cXmsFylsro%3D
24. V Gaddam DY Li JL Mehta 2002 Anti-thrombotic effects of atorvastatin-an effect unrelated to lipid lowering J Cardiovasc Pharmacol Ther 7 4 247 253 12490971 10.1177/107424840200700408 1:CAS:528:DC%2BD3sXkslSmtw%3D%3D (Pubitemid 35471361)
25. M Gomis, et al. 2010 Outcome of intracerebral haemorrhage patients pre-treated with statins Eur J Neurol 17 3 443 448 19912325 10.1111/j.1468-1331. 2009.02838.x 1:STN:280:DC%2BC3czitlKktQ%3D%3D
26. J Diedler, et al. 2010 Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset Stroke J Cereb Circ 41 2 288 294 10.1161/STROKEAHA.109.559724 1:CAS:528:DC%2BC3cXps1Slsw%3D%3D